Remove 2023 Remove Medicaid Remove Prescription Drug Pricing
article thumbnail

Magnolia Regional used price transparency IT to get more CHF patients to fill their prescriptions

Healthcare It News

"With prescription drug prices rising at every turn, patients need price transparency and the ability to discuss options with their doctors during office visits," Davis advised. ADVICE FOR OTHERS.

article thumbnail

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Jane Sarashon

In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.

ACA 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023

Health Law Advisor

This feedback must be submitted to CMS by March 11, 2023 via email ( IRARebateandNegotiation@cms.hhs.gov ). Manufacturers reportedly met with CMS on February 27, 2023, after the release of the Initial Inflation Rebate Guidances, to provide additional feedback on the rebate program.

article thumbnail

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Jane Sarashon

We’ve discussed the hockey-stick rise in the adoption and persistent use of GLP-1 drugs for managing diabetes and obesity here in Health Populi. This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6%

Doctors 59
article thumbnail

New York Enacts Landmark Legislation Regulating PBMs

Health Care Law Brief

On December 31, 2021, New York Governor Kathy Hochul signed landmark legislation to increase the transparency of prescription drug pricing and to establish requirements on pharmacy middlemen. Failure to obtain a license by 2023 could result in a cease and desist order from DFS and financial penalties. 1] [link].

article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Healthcare Law Blog

All rebate payments will be deposited into the Medicare Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund. The thirty-day public comment period ends on March 11, 2023. 7] What is the Effect on Coinsurance Rates under Part B? 9] What are Key Dates and Timelines?

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

CMS overhauls Direct Contracting model to include new requirements on governance, health equity in 2023. Why some Medicaid providers in Colorado aren’t getting paid. Whitmer signs bills designed to lower prescription drug prices in Michigan. Is this the year NC gets Medicaid expansion? NORTH CAROLINA.